Bausch Health Competitors and Similar CompaniesClear all
Bausch Health's competitors and similar companies include Pfizer, Merck, Novartis, GSK and Sanofi.
 Bausch Health Bausch Health is a company that develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. |  Merck Merck & Co (also known as Merck Sharp & Dohme) is a healthcare manufacturer and distributor of pharmaceuticals. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  GSK GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. |  Sanofi Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions. | |
Founding Date | Founding Date 1959 | Founding Date 1849 | Founding Date 1891 | Founding Date 1996 | Founding Date 2000 | Founding Date 2004 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | ||||||
Locations | Locations Laval, CA HQ Buenos Aires, AR Wien, AT Sarajevo, BA Indaiatuba, BR Porto Alegre, BR Sao Paulo, BR see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Bentley, AU Footscray, AU Mulgrave, AU Sydney, AU see more | Locations Rahway, US HQ Hydra, DZ Munro, AR Macquarie Park, AU Krems An Der Donau, AT Wien, AT Bruxelles, BE see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Brentford, GB HQ Boumerdes, DZ San Fernando, AR Abbotsford, AU Boronia, AU Ermington, AU Wien, AT see more | |
Employees | Employees 20,270 | Employees 83,0005% increase | Employees 72,0007% increase | Employees 76,057 | Employees 70,212 | Employees 86,088 |
Valuation ($) | Valuation ($) 3 b | Valuation ($) 163.9 b | Valuation ($) 294.7 b | Valuation ($) N/A | Valuation ($) 862.5 m | Valuation ($) 141.1 b |
Financial | ||||||
Revenue (est.) | Revenue (est.) $8.8b (FY, 2023) | Revenue (est.) $58.5b (FY, 2023) | Revenue (est.) $60.1b (FY, 2023) | Revenue (est.) $54.1b (FY, 2023) | Revenue (est.) £30.3b (FY, 2023) | Revenue (est.) €43.1b (FY, 2023) |
Cost of goods | Cost of goods $1.3b (FY, 2023) | Cost of goods $25b (FY, 2023) | Cost of goods $16.1b (FY, 2023) | Cost of goods $8.2b (FY, 2023) | Cost of goods £5.8b (FY, 2023) | Cost of goods €12.5b (FY, 2023) |
Gross profit | Gross profit $7.5b (FY, 2023) | Gross profit $33.5b (FY, 2023) | Gross profit $44b (FY, 2023) | Gross profit $47.7b (FY, 2023) | Gross profit £25.7b (FY, 2023) | Gross profit €34.5b (FY, 2023) |
Net income | Net income ($611m) (FY, 2023) | Net income $2.2b (FY, 2023) | Net income $377m (FY, 2023) | Net income $9b (FY, 2023) | Net income £5.3b (FY, 2023) | Net income €5.6b (FY, 2023) |
Operating ⚠ | ||||||
Countries | Countries N/A | Countries 125 (FY, 2021) | Countries N/A | Countries N/A | Countries 92 (FY, 2021) | Countries N/A |
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products 27 (FY, 2021) | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 16 (FY, 2021) | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products 25 (FY, 2021) | Phase II Trials Products 85 (FY, 2022) | Phase II Trials Products N/A | Phase II Trials Products 6 (FY, 2021) | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products 27 (FY, 2021) | Phase III Trials Products 32 (FY, 2022) | Phase III Trials Products 44 (FY, 2022) | Phase III Trials Products 11 (FY, 2021) | Phase III Trials Products N/A |
Projects in R&D Pipeline | Projects in R&D Pipeline 225 (FY, 2019) | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline 91 (FY, 2019) |
Registration Phase Products | Registration Phase Products N/A | Registration Phase Products 10 (FY, 2021) | Registration Phase Products N/A | Registration Phase Products 8 (FY, 2022) | Registration Phase Products N/A | Registration Phase Products N/A |
Suppliers | Suppliers N/A | Suppliers N/A | Suppliers N/A | Suppliers N/A | Suppliers 37.5 k (FY, 2021) | Suppliers 68 k (FY, 2019) |
Funding | ||||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 6.5m | Total funding raised N/A | Total funding raised $ 310m |
For sources of this data, please see the company profile
View Company Profiles
Pfizer
HQ
New York, US
Employees
83,000↑ 5% increase
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View companyMerck
HQ
Rahway, US
Employees
72,000↑ 7% increase
Merck & Co (also known as Merck Sharp & Dohme) is a healthcare manufacturer and distributor of pharmaceuticals.
View companyNovartis
HQ
Basel, CH
Employees
76,057
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyGSK
HQ
Brentford, GB
Employees
70,212
GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products.
View company